JPL to Help Oversee Space Station

WASHINGTON—The hiatus in U.S. unmanned planetary missions, caused by the explosion 13 months ago of the Space Shuttle Challenger, has made it possible for NASA's Jet Propulsion Laboratory (JPL) in Pasadena to take on a new role as manager for a portion of the agency's troubled space station program. The loss of Challenger has delayed for several years planned missions to Venus, Mars, Jupiter and explorations of the sun that will be carried out by the Laboratory, which is operated by the Ca

Written byJohn Rhea
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The loss of Challenger has delayed for several years planned missions to Venus, Mars, Jupiter and explorations of the sun that will be carried out by the Laboratory, which is operated by the California Institute of Technology. But it has allowed JPL to dispatch a team of 40 to 50 systems engineers and analysts to Washington to help to oversee the work to be done on the $13 billion space station.

"We're a creature of NASA," said JPL Director Lew Allen Jr. when asked if the Laboratory had requested a role in the space station. "They were looking for someone to help them out, and we're happy to make a contribution."

The JPL team will be led by Richard Laeser, who directed the Voyager project through its encounter with Uranus last winter and who has just completed preparations for its flight past Neptune in 1989. David Black will continue to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies